| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |